New Mouse Models for Gastric Cancer Research
Author Information
Author(s): Jessica Nöckel, Natasja K van den Engel, Hauke Winter, Rudolf A Hatz, Wolfgang Zimmermann, Robert Kammerer
Primary Institution: Ludwig-Maximilians-University, Munich, Germany
Hypothesis
The study aims to establish murine in vivo models to improve immunotherapies for gastric cancer.
Conclusion
The established tumor cell lines can be used to optimize immunotherapy regimens for gastric cancer.
Supporting Evidence
- The cell lines were established from gastric tumors of transgenic mice.
- All cell lines were tumorigenic when grafted into syngeneic hosts.
- Immunization with tumor cell lysates protected mice from tumor challenge.
Takeaway
Scientists created new mouse models to help test treatments for stomach cancer, which can be really hard to treat.
Methodology
Four cell lines were established from CEA424/SV40 T antigen-transgenic mice and three from double-transgenic mice, followed by various assays to assess tumorigenicity and immunogenicity.
Limitations
The study does not address the long-term efficacy of the immunotherapy strategies tested.
Participant Demographics
Mice used were C57BL/6 and various transgenic strains.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website